TP53 mutation spectrum in lung cancers and mutagenic signature of compenents of tobacco smoke: Lessons from the IARC TP53 mutation database [1]

Mutagenesis

Volumn 16, Issue 6, 2001, Pages 551-553

  Hainaut, Pierre ^a   Olivier, Magali ^a   Pfeifer, Gerd P ^b  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; CARCINOGEN; GUANINE; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE; THYMINE; TOBACCO SMOKE;

CLASSIFICATION; CODON; CONTROLLED STUDY; DATA BASE; HUMAN; LETTER; LUNG CANCER; METABOLITE; METHODOLOGY; MISSENSE MUTATION; MUTAGENICITY; NUCLEIC ACID BASE SUBSTITUTION; PREVALENCE; PRIORITY JOURNAL; PUBLICATION; STATISTICAL ANALYSIS;

DATABASES, FACTUAL; GENES, P53; HUMANS; LUNG NEOPLASMS; MUTAGENS; MUTATION; TOBACCO SMOKE POLLUTION;

NICOTIANA TABACUM;

EID: 0035171991     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (18)

1. Molecular epidemiology of human cancer risk: Gene-environment interactions and mutation spectrum in human lung cancer
2. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53
3. Slow repair of bulky DNA adducts along the nontranscribed strand of the human p53 gene may explain the strand bias of transversion mutations in cancers
4. Distribution of p53 and K-ras mutations in human lung cancer tissues
5. Mutations in the p53 tumour suppressor gene: Clues to cancer etiology and molecular pathogenesis
6. p53 and human cancer: The first ten thousand mutations
7. Patterns of G→T transversions in lung cancers reflect the primary mutagenic signature of DNA damage by tobacco smoke
8. A specific spectrum of p53 mutations in lung cancer from smokers: Review of mutations compiled in the IARC p53 database
9. Sources of bias in the detection and reporting of p53 mutations in human cancer: Analysis of the IARC p53 mutation database
10. Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer
11. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer
12. p53 mutation spectrum and load: The generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer
13. The K-ras gene regulates vascular endothelial growth factor gene expression in non-small cell lung cancers
14. A novel molecular staging protocol for non-small cell lung cancer
15. Analysis of different versions of the IARC p53 database with respect to G→T transversion mutation frequencies and mutation hotspots in lung cancer of smokers and non-smokers
16. Human lung cancer and p53: The interplay between mutagenesis and selection
17. Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons
18. p53 mutations in non-small cell lung cancer in Japan: Association between mutations and smoking